• Provider Login
  • Payors
  • Manufacturers
  • Blog
  • Careers
Avella Specialty Pharmacy
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact
Menu
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact

Specialty Pharmacy Insights

Return to blog

What is the Impact of Mobile Technology on Medication Adherence?

Posted by Avella Specialty Pharmacy on Mon, Aug 25, 2014
  • Tweet

SMSCaseStudyAs we have mentioned in our previous articles, healthcare is rapidly adopting new technologies to integrate data analytics for providers, streamline processes within medical practices, and help patients better manage their health.  With new digital innovations being introduced daily, it is now possible for consumers to better manage their own health and wellness through their portal devices accessing medical information, tracking their daily health, and even monitoring their vital signs.  

Seeing this transformation not only in specialty pharmacy, but heathcare as a whole, we performed a pilot study to see the influence of SMS (short message service), or more commonly called, text messaging, on adherence in the specialty population specifically related to refill rates.  Our hypothesis was that bi-directional SMS technology will improve patient and clinician engagement resulting in increased medication adherence.  After evaluting 94 patients, we saw a significant positive impact on refill rates.  Download the case study to learn more about the evaluation and view the full results.

What does this mean for the patient?

  • Easily manage refills to ensure medication dosages are not missed
  • Taking ownership of healthcare and being in better control of health outcomes
  • Avoid unnecessary trips to the doctor, or even the hospital, due to non-adherence

What does this mean for the provider?

  • Patients can more easily manage their own medications, saving your practice time and resources
  • Better communication with their specialty pharmacy on prescription updates and reminders
  • Improved patient health through increased medication adherence

In order to help improve patient health and increase medication adherence, we have built in a text messaging component to our mobile app.  For any patient who downloads the mobile app, they have access to refill their prescriptions, receive prescription updates, set medication reminders, and manage their doctor information.  With 2/3 of Americans owning a smart phone, we believe this is one of the most effective ways to communicate with patients in a manner that is most convenient for them.

We invite you to download our latest case study on the impact of SMS in medication adherence, and to learn more about our new pharmacy mobile app.

Download SMS Case Study Results

Topics Specialty Pharmacy Adherence

CONNECT WITH US

  • social-twitter
  • social-linkedin
  • social-youtube
  • social-facebook
  • social-yelp

Subscribe For Updates

Recent Posts

Posts by Topic

  • Avella (28)
  • Oncology (23)
  • Specialty Pharmacy (18)
  • Hepatitis (14)
  • Adherence (12)
  • HIV/AIDS (6)
  • Medication (6)
  • Cancer (5)
  • Fertility (5)
  • limited distribution drugs (4)
  • Accreditations (3)
  • Patients (3)
  • Public Health (3)
  • Addiction Management (2)
  • Pain Management (2)
  • mobile health (2)
  • 340b Program (1)
  • Complex Disease (1)
  • Dermatology (1)
  • IG Therapy (1)
  • In the News (1)
  • Inc (1)
  • Inc 5000 (1)
  • Industry News (1)
  • Infusion Therapy (1)
  • LLS (1)
  • Managed Care (1)
  • Partners (1)
  • Pharmacist (1)
  • Psoriasis (1)
  • RSV (1)
  • Rheumatoid Arthritis (1)
  • outsourcing facility (1)
  • payers (1)
see all
  • specialty_accreditation_seal-1
  • rsz_mail_service_accreditationseal
  • Addiction Management
  • Cardiovascular Disease
  • Dermatology
  • Fertility
  • Gastroenterology
  • Hepatitis
  • HIV / AIDS
  • Infusion Therapy
  • IG Therapy
  • Multiple Sclerosis
  • Oncology
  • Ophthalmology
  • Rheumatology
  • RSV
  • Transplant
  • Urology
  • Contact Avella
  • Terms of Use
  • Privacy
  • Blog
  • 877-546-5779
© 2025 Avella Specialty Pharmacy
  • Twitter
  • LinkedIn
  • YouTube
  • Facebook
.